Solving Problems Posed by Large Molecules

Add bookmark
Pharma IQ: In predictive toxicology what difference does the small molecule versus large molecule make? Stephen Kirk: The biggest difference is with regards to the small molecule there’s more of a structured process for predictive pre-clinical toxicological studies and you’re looking more for kind of off target toxicity, whereas with a larger molecule it’s very specific, so you’re looking more for an exaggerated pharmacology type response and looking for specific t...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended